HPC
CDMO

HM Payson & Co’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

HM Payson & Co’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-30
Closed – – 990
2019
Q4 		$0 Hold
30
– – ﹤0.01% 978
2019
Q3 		$0 Hold
30
– – ﹤0.01% 990
2019
Q2 		$0 Buy
+30
New +$124 ﹤0.01% 956

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

HM Payson & Co's CDMO Position: Q1 2020 in Review

HM Payson & Co sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2020, closing a stake of 30 shares.

HM Payson & Co first reported a position in CDMO in Q2 2019 and held it in 3 quarters. The position peaked at $0 in Q4 2019. 98 funds tracked by Wall St. Rank hold CDMO as of Q1 2020.

  • HM Payson & Co reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • HM Payson & Co sold 30 Avid Bioservices, Inc. Common Stock shares in Q1 2020.
  • HM Payson & Co first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • HM Payson & Co's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2020.

Based on HM Payson & Co's 13F filing for Q1 2020, filed 1 Jul 2020.